TGF-β promotes tumor invasion and metastasis by inducing an epithelial-mesenchymal transition (EMT). Long non-coding RNAs malat1 have been shown to play important regulatory roles in cancer progression. We therefore investigated whether TGF-β regulates malat1 expression to promote tumor metastasis of bladder cancer. We report that TGF-β induces malat1 expression and EMT in bladder cancer cells. Malat1 overexpression significantly correlates with poor survival in patients with bladder cancer. Malat1 and E-cadherin expression is negatively correlated in vitro and in vivo. Malat1 knockdown inhibits TGF-β-induced EMT.
Introduction
Human bladder cancer is one of the most common cancers worldwide (1) (2) . The majority of bladder cancers are urothelial cell carcinomas evolved from the epithelial lining of the bladder wall (3) (4) . The urothelial carcinomas are non-invasive tumors that commonly recur but rarely progress. Invasive bladder tumors are more aggressive.
Patients with invasive cancer have a much worse prognosis, with a 50% 5-year survival (5) . The advances in suitable therapy for the purpose of increasing survival rate have been limited because the molecular mechanisms causing metastasis are not entirely known. Revealing the underlying mechanism of bladder cancer metastasis is indispensable for developing effective therapy.
Long non-coding RNAs (lncRNAs) are a class of non-coding RNA longer than 200 nucleotides with no protein-coding capacity (7) . Through regulating gene expression by a variety of mechanisms, including transcription, post-transcriptional processing, genomic imprinting, chromatin modification and the regulation of protein function, lncRNAs have been shown to play important regulatory roles in diverse biological processes such as development, cell growth and tumorigenesis (8) (9) (10) .
HOTAIR expression level is higher in tumor tissues and HOTAIR overexpression is correlated with the presence of cancer metastasis (6) (7) . Forced expression of Author Manuscript Published OnlineFirst on January 21, 2014; DOI: 10.1158/1078-0432.CCR- HOTAIR in cancer cells leads to altered histone H3 lysine 27 (H3K27) methylation and abnormal gene expression, and increases cancer invasiveness and metastasis in a manner dependent on PRC2 (6) .
Suz12 or EZH2 functions as a H3K27 methyltransferase to selectively repress gene expression when comprising the PRC2 (8) . Suz12 is also required for E-cadherin repression by the Snail1 transcription factor (9) . In cancer cells, suz12 inhibition prevents the ability of Snail1 to downregulate E-cadherin and partially suppresses E-cadherin (9) . The means by which PRC2 targets specific chromatin regions is currently unclear, but lncRNAs have been shown to interact with PRC2 and facilitate its recruitment to promoter of some target genes (8, 10) .
Malat-1 (metastasis-associated lung adenocarcinoma transcript 1) is highly expressed in lung, pancreas and other healthy organs as well as in NSCLC (11) .
Malat1 overexpression is associated with metastasis and survival in NSCLC (11) .
Malat1 silencing impairs cell motility of lung cancer cells by regulating expression of migration-related genes (12) (13) . More recently, the role of malat1 in regulating bladder cancer progression is revealed. Malat1 contributes to bladder cancer cell migration by regulating EMT-associated ZEB1, ZEB2 and Slug levels (14) . However, the underlying mechanisms of malat1 regulating cancer metastasis remain unclear.
Based on these findings, we further investigated the molecular mechanism that malat1 regulates bladder cancer progression. In the study, we found that TGF-β-induced malat1 promotes EMT and subsequent bladder cancer metastasis by associating with suz12.
Research. Table S1） .
Quantitative real-time PCR
Total RNA was extracted from bladder cancer tissues or cells using Trizol reagent (Invitrogen, Carlsbad, CA), and the reverse-transcription reactions were performed using random primers. Real-time PCR was carried out using a standard SYBR Green PCR kit (Toyobo, Osaka, Japan) protocol on Applied Biosystems 7300
Real Time PCR system (Applied Biosystems, Foster City, CA). β-actin was used as references for lncRNAs or mRNA. The results were expressed as Log10 (2 -ΔΔCt ).
Western blot analysis
Western blot analysis to assess protein expression was performed as previously described (15) . The anti-E-cadherin, fibronectin, N-cadherin and MMP9 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The anti-β-actin primary
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The siRNA sequences and RNAi method were list in Supplementary Table S3 .
In vivo experiments
The male BALB/C nude mice were purchased from the Shanghai Experimental Animal Center of the Chinese Academy of Sciences (Shanghai, China), and were bred and maintained in a specific pathogen-free facility. For experimental metastasis assays, mice were implanted with 2×10 6 /50μl tumor cells by lateral tail vein injection.
Metastatic progression was monitored weekly and quantified using a noninvasive bioluminescence In Vivo Imaging System (IVIS) (Xenogen) as described previously (17) (18) . For spontaneous metastasis experiments, C57BL/6 mice were injected subcutaneously in one flank with 2 × 10 5 syngeneic MB49 cells, and lung metastasis were monitored after 6 weeks. Animals were divided into three groups which include malat1-siRNA treatment group, suz12-siRNA treatment group and MB49 control group.
Wound filling assay
RT4 or T24 (1~2×10 6 cells/well) cells were treated with malat1-siRNA or suz12-siRNA. Identical scratches were made in parallel wells 48 hours after transfection using a 1000 μl plastic pipette tip. The size of wound was measured and the percentage of the cells that had migrated was calculated.
Transwell invasion assay
Cell invasion was administrated using Transwell invasion assay with inserts of 8-µm pore size (Corning Costar) as described previously (19) .
Statistical Analysis
Data were presented as mean ± SD. The Student's t-test, χ2 test or Fisher's exact test were used for comparisons between groups. The Kaplan-Meier method was used to estimate overall survival, and multivariate Cox regression analysis with backward stepwise approach was used to test for independent prognostic factors. The difference was deemed statistically significant at p < 0.05.
Results

TGF-β induces malat1 expression and EMT in bladder cancer cells
TGF-β functions as a potent stimulator of bladder cancer cell migration and invasion (20) . Recent studies showed that malat1 is an lncRNA associated with metastasis and survival in early-stage non-small cell lung cancer (NSCLC) and bladder cancer (11, 14) . Therefore, we thought that TGF-β may upregulate malat1 to increase bladder cancer metastasis. We first confirmed that malat1 and EMT levels are regulated upon TGF-β treatment in bladder cancer cells. Figure.1A and B showed that malat1 is induced and peaked at 36 h after TGF-β treatment, which is followed by E-cadherin mRNA reduction in RT4 cells. Meanwhile, TGF-β treatment increases the mesenchymal markers (N-cadherin and fibronectin) mRNA levels (Supplementary We next examined the malat1 expression levels in bladder cancer tissues and adjacent normal control. Figure.1F showed that malat1 expression levels are significantly upregulated in most bladder cancer tissues compared with normal control (81%, n=95). When the tumor tissues were stratified based on clinical progression, we found that the TGF-β1 and malat1 levels are higher in primary tumors that subsequently metastasized than those in non-metastatic bladder cancer (Figure. Table S1 ). In addition, multivariate Cox regression analysis showed that malat1 expression, clinical stage and histological grade were independent prognostic indicators for overall survival (Supplementary Table S4 ). Expectedly, E-cadherin mRNA levels are lower in primary tumors that subsequently metastasized than those in non-metastatic bladder cancer ( Figure.1H ). These data suggest that TGF-β induces malat1 and EMT in bladder cancer.
Malat1 negatively regulates E-cadherin expression in bladder cancer cells
To define functional links between malat1 and EMT, we examined the effects of malat1 knockdown on E-cadherin expression. We first assayed the expression level of malat1 and E-cadherin in both noninvasive bladder cancer cell and invasive bladder cancer cell. Among the four invasive cell lines, the malat1 levels are relatively higher with concurrent low levels of E-cadherin compared with those in the three noninvasive ones ( Figure. 
Malat1 is associated with suppressor of zeste 12 (suz12)
LncRNA typically functions by binding to specific protein partner, served key regulatory roles to influence the activity of the proteins they bind (17) . Recent studies reported that lncRNA recruits polycomb-group proteins to regulate gene expression, and about twenty percent of all human lncRNAs have been shown to physically associate with the Polycomb Repressive Complex 2 (PRC2) (6, 21) . For example, HOTAIR is proved to achieve this by targeting ezh2 and suz12 to govern the cells' epigenetic state and subsequent gene expression (6, 22) . We therefore speculated that malat1 may regulate metastasis-related gene expression in such a manner. To test this, we performed RIP with antibodies against ezh2 or suz12 from nuclear extracts of T24 and RT4 cells. We observed a significant enrichment of malat1 with the suz12
antibody compared with the non-specific IgG antibody control ( Figure.3A) . These results were confirmed by using a different antibody against suz12 and another primer pair for malat1 to exclude potential nonspecific association ( Figure.3B ), but no 
enrichment of malat1 with the ezh2 antibody ( Figure.3C) . We then performed RNA pulldown to validate the association between malat1 and suz12. Figure.3D showed that malat1 can specifically combine and precipitate suz12, but no precipitation of suz12 by using lncRNA control. These data demonstrate that malat1 is specifically associated with suz12.
Malat1 represses E-cadherin expression by associating with suz12
In order to check whether expression of the E-cadherin is controlled by suz12, we analyzed the E-cadherin expression after suz12 overexpression or knockdown. As shown in Figure. 
TGF-β induces EMT by malat1/suz12 pathway
To further evaluate the role of malat1 in TGF-β-induced EMT, we examined effects of malat1 silencing on TGF-β-induced EMT markers. As shown in Figure. Similarly, using in T24 bladder cancer cells, malat1 or suz12 knockdown increases E-cadherin expression confirming in another cell line that malat1 or suz12 silencing can suppress TGF-β-induction of EMT ( Figure. 5D, E).
TGF-β promotes bladder cancer cell migration and metastasis by malat1/suz12 pathway in vitro and in vivo
The biological consequences of malat1 and suz12 in TGF-β regulation of invasion and migration were then examined using cell biology assays. Scratch assays showed that TGF-β-induced cell migration is almost abolished by malat1 and suz12 knockdown in RT4 and T24 cells ( Figure.6A, B) . Moreover, we found that malat1 or suz12 silencing significantly decreases basal matrix metalloproteinase-9 (MMP-9) activity ( Figure.6C, D) . So we further investigated the role of malat1 in cell invasion.
The bladder cancer cells were treated with malat1-siRNA or suz12-siRNA and cell invasion was analyzed. As shown in Figure. 
Discussion
Large scale complementary DNA cloning projects has identified that majority of the mammalian genome is transcribed, and only minority of these transcripts represents protein-coding genes (23) . lncRNAs have been shown to plays an important role in diverse biological processes such as development, cell growth and tumorigenesis (24) (25) . More recently, lncRNAs have also been implicated in regulating specific steps in the metastatic cascade. Because metastasis is the major cause of death for bladder cancer patients, it stands to reason that defining the molecular mechanisms whereby lncRNAs have an impact on metastasis may provide novel opportunities to treat metastatic bladder cancers.
Malat1 is one of the first cancer-associated lncRNAs. Malat1 level is upregulated in cancer tissues and its dysregulation is discovered as a marker for metastasis development in early stages of lung adenocarcinoma (11) and more recently in bladder cancer (14) . However, its functional role in this process was only beginning to emerge by virtue of its link to cell migration. Malat1 positively regulates cell motility through the concomitant regulation of motility-related genes (12). Ying et al showed that upregulated malat1 promotes to bladder cancer cell migration by inducing EMT (14) . It is also well known that increased levels of TGF-β in bladder cancer patients have significant prognostic value for highly aggressive metastatic disease and are considered a poor prognosis marker (26) (27) . One mechanism by which TGF-β contributes to cancer progression is through induction of EMT. Based on these findings, we speculated upregulated TGF-β may increase EMT by the regulation of Recent studies reported that about twenty percent of all human lncRNAs have been shown to physically associate with the PRC2 (6, 21) . HOTAIR is proved to achieve this by targeting ezh2 and suz12 to govern the cells' epigenetic state and subsequent gene expression (6, 22) . PRC2 is also required for E-cadherin repression (9). Herranz et al showed that Snail1 recruits PRC2 to the E-cadherin promoter and requires the activity of this complex to repress E-cadherin expression. Therefore we thought that malat1 may regulate EMT by recruiting PRC2. In fact, our results demonstrated that malat1 is associated with suz12, and that this association results in E-cadherin downregulation and N-cadherin and fibronectin upregulation. These results show data from at least three independent experiments, expressed as the mean ± SD. *p < 0.05. 
